SEC Form 4 · accession 0001209191-15-028961
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne Joseph Riley
Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | M | 10,000 | $59.55 | A | 10,400 | D | |
| Common Stock | Mar 20, 2015 | S | 10,000 | $135.08 | D | 400 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $59.55 | Mar 20, 2015 | M | 10,000 | D | — | May 31, 2022 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1.
- F2Fully vested.